Clinical Sales Specialist (CS) - Jacksonville South at Corcept Therapeutics

Jacksonville, Florida, United States

Apply Now

$140,000 – $155,000Compensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

NoVisa

Pharmaceuticals, BiotechnologyIndustries

Requirements

BA/BS or equivalent work experience
5+ years sales experience
Recent endocrine relationships, specialty therapeutic, hospital, or orphan drugs sales experience highly preferred
Proven track record of consistent high performance
Strong ability to collaborate and work cross-functionally
Willingness to travel up to 100% of the time, including up to 40% overnight travel
Ability to lift and/or move up to 35 pounds
Currently authorized to work in the United States on a full-time basis

Responsibilities

Build and develop professional relationships with influential high prescribers and thought leaders in the territory
Leverage expertise to anticipate and manage business opportunities and challenges
Develop and implement effective customer-specific territory plans and communicate insights to internal stakeholders
Prioritize time and effort to ensure optimal coverage of appropriate physician specialists
Plan and participate in education programs and speaker dinner programs
Manage territory expenses/budget to support sales and marketing activities

Skills

Key technologies and capabilities for this role

Pharmaceutical SalesSales Territory ManagementKey Opinion Leader EngagementEndocrinology SalesOrphan Drug SalesCross-functional CollaborationSpeaker ProgramsBudget ManagementHigh Prescriber Relationships

Questions & Answers

Common questions about this position

What is the salary range for the Clinical Sales Specialist position?

The salary range is $140,000 - $155,000.

Is this position remote or does it require office work?

The position is remote.

What skills and experience are required for this role?

Requirements include a BA/BS or equivalent, 5+ years of sales experience, and recent experience in endocrine relationships, specialty therapeutics, hospitals, or orphan drugs is highly preferred. Preferred skills include a proven track record of high performance, strong cross-functional collaboration, willingness to travel up to 100% (including 40% overnight), and ability to lift up to 35 pounds.

What is the travel requirement for this job?

The role requires willingness to travel up to 100% of the time, including up to 40% overnight travel.

What makes a strong candidate for this position?

Strong candidates have 5+ years of sales experience, preferably in endocrine, specialty therapeutics, hospital, or orphan drugs, a proven track record of high performance, strong collaboration skills, and are willing to travel extensively. A BA/BS or equivalent is required, and applicants must be authorized to work full-time in the US.

Corcept Therapeutics

Develops cortisol modulators for medical conditions

About Corcept Therapeutics

Corcept Therapeutics focuses on developing treatments that regulate cortisol levels in the body, which is important for managing various health issues. Their main product, Korlym, is used to treat Cushing's syndrome, a condition caused by too much cortisol. Korlym was approved by the FDA in 2012 and is the first medication specifically for this disorder. Corcept stands out from competitors by having a strong emphasis on research and development, having discovered over 1,000 unique cortisol modulators. The company aims to expand its range of treatments while also providing educational resources to healthcare professionals and patients to improve understanding and care for cortisol-related conditions.

Menlo Park, CaliforniaHeadquarters

1998Year Founded

$39.7MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

201-500Employees

Benefits

Remote Work Options

Flexible Work Hours

Risks

Teva's antitrust lawsuit could lead to legal expenses and market share loss.

Heavy reliance on Korlym makes Corcept vulnerable to market fluctuations.

Recent investments may pressure Corcept for short-term financial performance, impacting R&D.

Differentiation

Corcept specializes in cortisol modulation, a niche with few direct competitors.

Korlym is the first FDA-approved treatment for Cushing's syndrome, a significant market advantage.

Corcept's extensive R&D has led to the discovery of over 1,000 selective cortisol modulators.

Upsides

Increased interest in cortisol therapies for mental health boosts Corcept's R&D prospects.

Advancements in drug delivery systems could enhance Corcept's product efficacy.

The FDA's fast-track designation supports Corcept's innovative cortisol-related treatments.

Land your dream remote job 3x faster with AI

Try Jobo Free